Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Mesenchymal stem cells (MSCs) are the major source of osteoblasts. Long noncoding RNAs (lncRNAs) are abundantly expressed RNAs that lack protein-coding potential and play an extensive regulatory role in cellular biological activities. However, the regulatory network of lncRNAs in MSC osteogenesis needs further investigation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>QRT-PCR, western blot, immunofluorescence, and immunohistochemistry assays were used to determine the levels of relevant genes. The osteogenic differentiation capability was evaluated by using Alizarin Red S (ARS) staining, alkaline phosphatase activity assays, hematoxylin & eosin staining or micro-CT. RNA fluorescence in situ hybridization (FISH) and RNAscope were used to detect HHAS1 expression in cells and bone tissue. A microarray assay was performed to identify differentially expressed microRNAs. RNA immunoprecipitation and RNA pull-down were used to explore the interactions between related proteins and nucleic acids.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The level of lncRNA HHAS1 increased during bone marrow-derived MSC (BMSC) osteogenesis and was positively related to the levels of osteogenic genes and ARS intensity. HHAS1 was located in both the cytoplasm and the nucleus and was expressed in human bone tissue. HHAS1 facilitated BMSC osteogenic differentiation by downregulating miR-204-5p expression and enhancing the level of RUNX family transcription factor 2 (RUNX2). In addition, interferon regulatory factor 2 (IRF2) was increased during BMSC osteogenic differentiation and interacted with the promoter of HHAS1, which resulted in the transcriptional activation of HHAS1. Furthermore, IRF2 and HHAS1 helped improve bone defect repair in vivo.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our study identified a novel lncRNA, HHAS1, that facilitates BMSC osteogenic differentiation and proposed a role for the IRF2/HHAS1/miR-204-5p/RUNX2 axis in BMSC osteogenesis regulation. These findings help elucidate the regulatory network of BMSC osteogenesis and provide potential targets for clinical application.</p></section>

Β-Catenin-coordinated Lncrna MALAT1 Up-Regulation of ZEB-1 Could Enhance the Telomerase Activity in HGF-mediated Differentiation of Bone Marrow Mesenchymal Stem Cells into Hepatocytes

MALAT1/ miR-1-3p-mediated BRF2 promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

Interaction of Lncrna-Malat1 and Mir-124 Regulates HBx-induced Cancer Stem Cell Properties in HepG2 Through PI3K/Akt Signaling.

Retraction Note: Upregulation of Long Noncoding RNA ZEB1-AS1 Promotes Tumor Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma

Down-regulation of Wnt Signaling Could Promote Bone Marrow-Derived Mesenchymal Stem Cells to Differentiate into Hepatocytes

The Role of Lncrna MALAT1 in the Regulation of Hepatocyte Proliferation During Liver Regeneration

HBx-related Long Non-Coding RNA MALAT1 Promotes Cell Metastasis Via Up-Regulating LTBP3 in Hepatocellular Carcinoma.

Long Noncoding RNA Metastasis-Associated Lung Carcinoma Transcript 1 (MALAT1) Inhibits Bone Marrow Mesenchymal Stem Cell Formation Through Regulating Smad/Runx2 Signaling Pathway

MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.

LncRNA LINC00707 Promotes Osteogenic Differentiation of Hbmscs Through the Wnt/β-catenin Pathway Activated by LINC00707/miR-145/LRP5 Axis.

LncZEB1-AS1 Regulates Hepatocellular Carcinoma Bone Metastasis Via Regulation of the Mir-302B-egfr-pi3k-akt Axis

lncRNA MALAT1 mediates osteogenic differentiation of bone mesenchymal stem cells by sponging miR-129-5p

Malat1 Modulates Tgf-Beta 1 Nduced Endothelial-To-Mesenchymal Transition Through Downregulation Of Mir-145

Activation of LTBP3 Gene by a Long Noncoding RNA (lncrna) MALAT1 Transcript in Mesenchymal Stem Cells from Multiple Myeloma

Hepatocyte Growth Factor-induced Differentiation of BMSCs Toward Hepatocyte-like Cells Via the NF-κB and P38MAPK Signaling Pathway

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

IRF2‐mediated upregulation of lncRNA HHAS1 facilitates the osteogenic differentiation of bone marrow‐derived mesenchymal stem cells by acting as a competing endogenous RNA

Expression of Hepatocyte-Like Phenotypes in Bone Marrow Stromal Cells after HGF Induction.

Differentiation of Mesenchymal Stem Cells into Cardiomyocytes is Regulated by Mirna-1-2 Via WNT Signaling Pathway

Hepatoblastoma: Derived Exosomal LncRNA NEAT1 Induces BMSCs Differentiation into Tumor-Supporting Myofibroblasts via Modulating the miR-132/MMP9 Axis

An Integrated Transcriptomics and Proteomics Analysis Implicates lncRNA MALAT1 in the Regulation of Lipid Metabolism